MyFinsight
Home
Blog
About
Cash
$1,628,625
(-44.31%↓ Y/Y)
Prepaid expenses
$298,817
(-81.10%↓ Y/Y)
Total current assets
$1,927,442
(-57.22%↓ Y/Y)
Total assets
$1,927,442
(-57.22%↓ Y/Y)
Total liabilities and
stockholders equity
$1,927,442
(-57.22%↓ Y/Y)
Total stockholders
equity
$1,278,519
(-66.33%↓ Y/Y)
Total liabilities
$648,923
(-8.41%↓ Y/Y)
Accumulated deficit
-$248,156,684
(-1.30%↓ Y/Y)
Additional paid-in capital
$247,728,818
(0.27%↑ Y/Y)
Total current
liabilities
$492,759
(-16.88%↓ Y/Y)
Derivative financial
instrumentswarrants
$156,164
(35.00%↑ Y/Y)
Convertible preferred
stock-Series APreferred...
$855,808
(0.00%↑ Y/Y)
Convertible preferred
stock-Series CPreferred...
$839,320
(0.00%↑ Y/Y)
Accumulated other
comprehensive income
$8,345
(0.00%↑ Y/Y)
Common stock0.0001 par
value per share...
$2,912
(150.60%↑ Y/Y)
Accrued expenses
$322,884
(565.81%↑ Y/Y)
Accounts payable
$169,875
(-1.63%↓ Y/Y)
Back
Back
Balance Sheet
Hepion Pharmaceuticals, Inc. (HEPA)
Hepion Pharmaceuticals, Inc. (HEPA)
source: myfinsight.com